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        Type 1 IFNs (IFN-     /     ) are a family of cytokines 
with a wide range of antiviral and immuno-
regulatory eff  ects (  1  –  6  ). Binding to their het-
erodimeric IFN-     /      receptor (IFNAR) is 
under  stood to activate signal transducer and acti-
vator of transcription 2 (STAT2) and STAT1, 
with their phosphorylation leading to the for-
mation of a transcriptional complex including 
STAT1  –  STAT2 heterodimers and induction of 
interferon-stimulated genes (  5, 7, 8  ). STAT1  –
  STAT1 homodimers can be activated by stimu-
lation of the receptors for either type 1 IFNs or 
IFN-      (  5, 7  ) to result in overlapping induction 
of certain genes (  2, 4  –  6  ). In addition to STAT1 
and STAT2, type 1 IFNs have been reported 
to conditionally activate all of the STATs, in-
cluding STAT4 (  3, 9  ). This fl  exibility may pro-
vide an explanation for how their functions are 
extended from antiviral eff  ects to regulation of 
immune responses, but the understanding of 
the mechanisms in place to preferentially access 
diff  erent signaling pathways is limited. Based on 
the observations that STAT1 levels are induced 
during viral infections, and that this negatively 
correlates with type 1 IFN activation of STAT4 
in mixed populations ex vivo, this laboratory has 
proposed that access to either of the two signal-
ing molecules is a consequence of the relative 
concentration of STAT1 (  10  ). However, the 
in vivo pathways coordinating these events, 
their biological importance, and the mecha-
nisms for how changing STAT1 levels acts to 
limit access to STAT4 remain unknown. 
  NK cells are major contributors to innate 
IFN-      production (  11  ). Because NK cells can 
produce high levels of IFN-     , they may be par-
ticularly well adapted for making the cytokine 
(  12, 13  ). Under conditions of cytokine stimula-
tion for IFN-      production, activation of STAT4 
is important for peak responses (  14, 15  ). Type 1 
IFNs can induce IFN-      (  3, 9, 10, 13, 16  –  20  ). 
They are not potent inducers of peak NK cell 
IFN-      production under immunocompetent 
conditions of viral infections (  14, 15  ), however, 
and they have an additional paradoxical func-
tion for negatively regulating NK cell IFN-      
responses (  13  ). The inhibitory eff  ect of type 1 
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driven during viral infection by either type 1 IFN or IFN-    , are associated with decreased 
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The regulation occurs with an NK cell type 1 IFN receptor switch from a STAT4 to a STAT1 
association. Thus, a fundamental characteristic of NK cells is high STAT4 bound to the type 1 
IFN receptor. The conditions of infection result in STAT1 induction with displacement of 
STAT4. These studies elucidate the critical role of STAT4 levels in predisposing selection of 
specifi  c signaling pathways, defi  ne the biological importance of regulation within particular 
cell lineages, and provide mechanistic insights for how this is accomplished in vivo. 2384 STATS AND TYPE 1 IFN EFFECTS ON NK CELLS | Miyagi et al.
after type 1 IFN treatment in only WT populations. There 
was uniform shift in the intensity of cytoplasmic staining (  Fig. 
1 A  ). Total STAT4 was detected by Western blot in WT, but 
not STAT4  −   cells, and pSTAT4 was induced after type 1 IFN 
treatment in only WT populations. It was diffi   cult to detect 
STAT4 in the mixed populations, however, and pSTAT4-
positive cells were a small subset (  Fig. 1 B  ). 
  NK cells are      5% of splenic leukocytes. To evaluate 
diff  erential STAT levels in NK cells, populations from WT 
129 mice were used to prepare total, NK (enriched to      90% 
purity by CD49b-positive selection), and non-NK (CD49b-
negative) populations. Proteins were extracted for Western 
blot analysis. Compared with      -actin, NK cells expressed 
    10  –  20-fold more STAT4 protein than total or non-NK 
cells (  Fig. 1 C  ). Similar diff  erences were observed evaluating 
intracellular staining of the mixed populations with gating on 
total viable, CD49b CD3      NK cells, or CD49b  −  non-NK 
cells. Peak STAT4 expression in all but NK cells was low at 
a fl  uorescent intensity within 1 log. In contrast, 75% of NK 
cells had high STAT4 expression, with populations into the 
second log of intensity (  Fig. 1 D  ). The STAT1 levels were 
low in the three diff  erent populations, but NK cells routinely 
had the lowest levels using either method of analysis (  Fig. 
1, C and D  ). Thus, NK cells have an unusually high basal 
STAT4 and lower STAT1 expression. 
  To examine the levels of these signaling molecules dur-
ing infection, 129 mice were either uninfected or challenged 
with 2       10  4   PFUs of LCMV on day 0 (D0). At D0 or D1.5 
and D2.5 after infection, splenic leukocytes were harvested, 
and the total or NK (CD49b CD3     ) cells were evalu-
ated for intracellular expression of STAT4 compared with 
STAT1. The STAT4 levels were relatively constant and low 
in the total leukocyte populations on D0, D1.5, and D2.5. 
In contrast, the STAT1 levels were dramatically increased 
with 67  –  75% of the populations having high expression af-
ter infection (  Fig. 1 E  ). The NK cells consistently expressed 
higher levels of STAT4, but also had dramatic increases in 
STAT1, from      2 to      70% positive, during infection (  Fig. 
1 F  ). Hence, high levels of STAT4 are sustained in NK cells 
and not in total populations, but STAT1 levels are dramati-
cally induced in all of the cells during early viral infection. 
  Activation of STAT4 and STAT1 
  To evaluate the activation of the STATs in vivo, fl  ow cyto-
metric analyses were performed for intracellular expression of 
pSTAT4 or pSTAT1. Immediately after harvest, there was no 
evidence of phosphorylated STATs in total (  Fig. 1 G  ) or NK 
(CD49b CD3     ;   Fig. 1 H  ) cells prepared from uninfected 
mice (D0). There was a reproducible detection of a small pro-
portion (7%) of pSTAT4-positive NK cells on D1.5 that was 
not observed in any of the other populations examined. Both 
total and NK cell populations were     20% pSTAT1 positive 
on D1.5 and 10% pSTAT1 positive on D2.5. Thus, all of 
the examined populations are responding to the conditions of 
viral infection with activation of STAT1, and a small popula-
tion of NK cells is responding with activation of STAT4. 
IFN may be important for promoting health because IFN-      
can also contribute to cytokine-mediated disease (  21  –  25  ). The 
mechanisms for selecting between enhancement and inhibi-
tion are not clear, and much remains to be learned about how 
NK cells are simultaneously predisposed to be good IFN-      
producers, but tightly regulated to protect against detrimental 
responses. The relationship between type 1 IFNs and access to 
STATs may be important in the control. 
  The experiments presented here evaluate the expression 
and function of STATs within NK cells responding in vivo. 
They were performed in the context of the lymphocytic cho-
riomeningitis virus (LCMV) infection inducing a dominant 
type 1 IFN innate cytokine response in mice (  12, 26  –  29  ). The 
results demonstrate that NK cells are predisposed to STAT4 
pathways and have an unusual sensitivity for type 1 IFN acti-
vation of STAT4 because their basal expression of this protein 
is substantially higher in comparison to other populations. 
Dramatic increases in STAT1 are, however, elevated in all 
cells during infection. In the presence of STAT2, type 1 IFNs 
induce a rapid increase in STAT1. In the absence of STAT2, 
an early IFN-      production induces STAT1 with delayed 
kinetics. Characterization of responses in immunocompetent 
compared with STAT1- or STAT2-defi  cient mice identify 
the importance of elevated STAT1 for inhibition of the type 1 
IFN pathway to STAT4. The changes in STAT4 sensitivity 
are accompanied by a displacement of its association with the 
type 1 IFN receptor; STAT4 is coprecipitated with IFNAR 
in NK cells, but not total or non-NK cells, from uninfected 
mice, but increased STAT1 is coprecipitated with the recep-
tor in all populations after infection. These results defi  ne the 
critical role of basal STAT4 levels in predisposing selection of 
signaling pathways, and suggest basal STAT4 association with 
the type 1 IFN receptor as a mechanism for the preferential 
access. Collectively, the studies precisely map intracellular 
signaling pathways regulating type 1 IFN eff  ects, and dem-
onstrate how modifi  cation of accessibility is shaped to control 
immune responses. 
    RESULTS   
  Expression of STAT4 and STAT1 
  Flow cytometric techniques were developed to measure 
intracellular levels of total STAT1 and STAT4 proteins, 
as well as their active phosphorylated forms, pSTAT1 and 
pSTAT4. To validate the approach, splenic leukocytes from 
WT, STAT1-defi  cient, or STAT4-defi  cient C57BL/6 mice 
were isolated and control-treated or treated with a type 1 
IFN (recombinant mouse [rm] IFN-     ) for 90 min in culture. 
Isotype staining was also performed as a control. Results were 
compared with those observed with cell lysates evaluated in 
Western blot analyses using      -actin measurements for pro-
tein loading control. A variety of antibodies reported to be 
specifi  c for the total or activated STATs were screened. Re-
sults obtained with those determined to be the most specifi  c 
for the application are shown in   Fig. 1  .   Total STAT1 was 
detected by both Western blot and fl  ow cytometric analyses 
in WT, but not STAT1  −  cells, and pSTAT1 was induced JEM VOL. 204, October 1, 2007 
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  To examine cellular responsiveness to type 1 IFN for 
STAT activation, cells isolated on D0, D1.5, and D2.5 
were rested at 37  °  C for 4 h without cytokine stimulation 
to allow for   “  clearing  ”   of signals delivered in vivo, and then 
control-treated or treated with IFN-      for 90 min. Flow cyto-
metric analyses evaluated pSTAT1 and pSTAT4 (  Fig. 2  ). 
  The total and NK cells were all type 1 IFN responsive, and 
they maintained this responsiveness during infection. Total 
populations had relatively uniform shifts in pSTAT1 stain-
ing after IFN treatment, with 36  –  43% of the cells becoming 
highly positive. The NK cells also responded with pSTAT1, 
but the populations were more heterogeneous on D0, with 
  Figure 1.     In vivo expression of STAT1 and STAT4. Total STAT1, 
pSTAT1, total STAT4, or pSTAT4 protein levels were evaluated in splenic cell 
lysates by Western blot analyses, with      -actin measurements as a loading 
control, or within individual cells by fl  ow cytometry with antibody isotype 
control staining. Techniques were validated (A and B) using samples 
derived from WT, STAT1-defi  cient, or STAT4-defi  cient mice. Cells were 
control treated or treated with rmIFN-      in culture (see Materials and 
methods). In the histograms of the fl  ow cytometric staining analyses, 
results presented by dotted lines are isotype controls, gray areas are total 
STATs or pSTATs in control WT cells, and thick lines are pSTATs in control 
WT cells treated with IFN-     . The thin lines show results using the respec-
tive STAT-defi  cient cells for total STATs or for pSTATs after treatment with 
IFN-     . Subset levels of STAT expression were evaluated with splenic 
leukocytes from uninfected WT mice by Western blot analysis of lysates 
collected from “total” cells, or subsets separated into NK (CD49b+) and 
non-NK (CD49b ) cells (C), and histograms of fl  ow cytometric analyses 
of STAT4 and STAT1 expression in gated total, CD49b CD3  NK, and 
non-NK cells (D). The effects of LCMV infection on  STAT (E and F) and 
pSTAT (G and H) levels were evaluated with freshly isolated cells (E and F) 
with splenic leukocytes derived from uninfected or D1.5- and D2.5-
infected WT mice. Histograms present levels in total (E and G) and 
CD49b CD3  NK (F and H) cells. Numbers are the means   the SEM of 
positive cell percentages compared with the isotype controls from three 
mice in each group. Data are representative of more than three indepen-
dent experiments. 
  Figure 2.     Ex vivo responsiveness to type 1 IFN for activation of 
STAT1 and STAT4. Cells were prepared from uninfected or mice infected 
with LCMV for 1.5 or 2.5 d. Responsiveness of   “  rested  ”   cells to type 1 IFN 
for STAT4 and STAT1 activation was determined using splenic leukocytes 
incubated without the addition of cytokines for 4 h, and then either un-
stimulated or stimulated with rmIFN-      for 90 min. Cells were collected 
and stained to detect intracellular pSTAT4 and pSTAT1 expression within 
total and NK cells using fl  ow cytometry. Histogram plot graphs (linear 
y axes of cell number) represent pSTAT1 (top) or pSTAT4 (bottom) staining. 
Dotted lines show staining with isotype controls. Gray areas or solid lines 
show staining of untreated cells or IFN-     – treated  cells,  respectively. 
Numbers given are means, with SEMs in parentheses, of percentages of 
positive cells in IFN-       –  treated cells, compared with isotype controls. Data 
are representative of more than three independent experiments.     2386 STATS AND TYPE 1 IFN EFFECTS ON NK CELLS | Miyagi et al.
advantage of IFNAR (IFN          R)-defi  cient, IFN-      R  –  defi  -
cient, and double receptor (IFN-     /     /      R)  –  defi  cient com-
pared with WT 129 mice. Mice were uninfected or LCMV 
infected for 1.5 d. Splenic leukocytes were harvested, and total 
STAT1 protein levels were determined by Western blot (  Fig. 
3 A  ).   At D1.5 after infection, STAT1 induction was primarily 
dependent on type 1 IFN, but not IFN-      function. Absence 
of responsiveness to both cytokines resulted in a complete 
block in STAT1 induction. Flow cytometric studies examin-
ing levels within total (  Fig. 3 B  ) and gated CD49b CD3      
NK (  Fig. 3 C  ) cells gave similar results. Thus, the peak early 
induction of STAT1 is primarily dependent on responsive-
ness to type 1 IFN. 
  Type 1 IFN signaling is predisposed to using STAT2 
and STAT1, whereas IFN-      signaling is STAT1 dependent, 
but STAT2 independent (  2, 5, 6  ). The STAT2 signaling 
requirement was evaluated by examining STAT1 induction 
in STAT2-defi  cient mice compared with WT and STAT1-
defi  cient mice. Infection of WT mice induced STAT1 to 
high levels, with densities increased by 2.6  –  3-fold at D1.5 
24% becoming highly positive, and the proportions of highly 
positive cells increasing to 45 and 53% on D1.5 and D2.5, 
respectively, after infection (  Fig. 2  , top). Total populations 
were relatively insensitive for STAT4 activation at all times 
examined (  Fig. 2  , bottom). In contrast, there was a dramatic 
pSTAT4 response of the D0 NK cells; 58% of these cells had 
high-intensity staining for pSTAT4. The STAT4 response 
was greatly diminished after infection, with only 5  –  10% of 
the NK cell populations prepared on D1.5 or 2.5 of infec-
tion demonstrating STAT4 activation. Collectively, the re-
sults show that all cells prepared from uninfected and infected 
mice are able to respond to type 1 IFN with STAT1 activa-
tion, but NK cells are uniquely armed to dramatically re-
spond with STAT4 activation. This STAT4 phosphorylation 
response is diminished during infection. 
  Regulation of STAT1 protein expression 
  Because both type 1 IFN and IFN-      have been reported to 
induce STAT1 in culture (  30  ), their contribution to in vivo 
STAT1 induction was evaluated. These experiments took 
  Figure 3.     Regulation of STAT1 expression. Total STAT1 protein levels were evaluated in cell lysates by Western blot analyses with     -actin  measure-
ments as a loading control (A, D, and G) or within individual cells by fl  ow cytometry, electronically gating on total (B, E, and H) and on CD49b CD3    NK 
(C, F, and I) cells. Splenic leukocytes were derived from uninfected or D1.5 LCMV-infected WT, IFNAR-defi  cient, IFN-    R – defi  cient mice, or IFN-    /   /   R –
 defi  cient mice (A  –  C). Splenic leukocytes were derived from uninfected or 1.5- and 2.5-d LCMV-infected WT, STAT2-defi  cient, or STAT1-defi  cient mice (D  –  F). 
Splenic leukocytes were derived from uninfected, anti  –  IFN-      antibody  –  treated, or control Ig  –  treated D2.5 LCMV-infected WT and STAT2-defi  cient mice 
(G  –  I). The numbers in all histograms represent means       the SEM of three mice in each group of percentages of STAT1-positive cells, compared with the 
isotype control. Data presented are representative of more than three independent experiments.     JEM VOL. 204, October 1, 2007 
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Much higher levels of IFN-      were observed in the popula-
tions isolated from LCMV-infected STAT1-defi  cient mice 
on either D1.5 or D2.5. In STAT2-defi  cient mice on D1.5, 
STAT1 expression was still low in most of the NK cells and the 
induced IFN-      expression was detectable in these cells as com-
pared with the NK cells already having high STAT1 levels. 
and D2.5 (  Fig. 3 D  ). Although infection also induced STAT1 
in STAT2-defi  cient mice, the eff  ect was delayed. The levels 
were lower at D1.5 than those in WT mice, showing only a 
1.6-fold increase compared with D0, but the molecule was 
induced to comparable levels, with a 2.8-fold increase by 
D2.5 after infection. Flow cytometric experiments yielded 
similar results with total (  Fig. 3 E  ) and NK (  Fig. 3 F  ) cells 
isolated from STAT2-defi  cient infected mice displaying de-
layed induction of STAT1. These studies demonstrate that 
the presence of STAT2 is accompanied by an accelerated 
induction of STAT1, but a STAT2-independent pathway to 
STAT1 induction occurs with delayed kinetics. 
  To examine the contribution of endogenously induced 
IFN-      to STAT1 induction in the STAT2-defi  cient mice, 
infected mice were control-treated or treated with antibodies 
neutralizing IFN-      (  Fig. 3, G  –  I  ). Although neutralization of 
IFN-      only modestly reduced the levels of STAT1 induced 
on D2.5 after infection of WT mice, there was a 3  –  5-fold 
decrease resulting from IFN-      neutralization in STAT2-
defi  cient mice, and this was also apparent in NK cells. Thus, 
type 1 IFN provides a dominant pathway and IFN-      pro-
vides an accessory pathway to STAT1 induction, but in the 
absence of the STAT2-dependent type 1 IFN eff  ect, IFN-      
is critically involved in STAT1 induction. 
  IFN-     and pSTAT4 responses in the context of changing 
STAT1 levels 
  Serum samples were taken at diff  erent times after infections 
and evaluated by ELISA to compare IFN-      responses in 
STAT2- to STAT1-defi  cient and WT mice. Consistent with 
our previous results (  13, 31  ), immunocompetent mice had 
only minimal, but STAT1-defi  cient mice had profound, 
IFN-      responses in the circulation on D1.5, D2, D2.5, and 
D3 after LCMV infection (  Fig. 4 A  ).   In STAT2-defi  cient 
mice, increased IFN-      production was observed at D1.5 after 
infection, but the values returned to near normal by D2.5. 
Flow cytometric studies performed to evaluate the propor-
tions of NK cells and their expression of IFN-      demonstrated 
that the frequencies of NK cells were similar, with all strains 
showing modest reductions after infection (  Fig. 4 B  ). NK 
cells only expressed IFN-      at very low levels during infec-
tion of WT mice (  Fig. 4 C  ). In STAT1-defi  cient mice, how-
ever, as many as 10  –  20% of the NK cells were high-intensity 
IFN-      positive at D1.5 and D2.5. In STAT2-defi  cient mice, 
    15% of the NK cells were high-intensity IFN-      positive at 
D1.5, but at D2.5      2% expressed the cytokine, and only with 
low intensity. Thus, NK cells can be major contributors to 
early IFN-      responses during viral infection, but their response 
is tightly regulated in WT mice and with delayed kinetics in 
STAT2  −  , but not STAT1  −  , mice. 
  To determine the relationship between total STAT1 lev-
els and IFN-      expression within individual NK cells, concur-
rent intracellular expression of these molecules was examined 
immediately after isolation (  Fig. 5 A  ).   During infection of 
WT mice, the NK cells with dramatically increased STAT1 
had only low-level intracellular IFN-      expression detectable. 
  Figure 4.     Role of STAT1 or STAT2 in regulating IFN-      production. 
The IFN-      responses were evaluated in serum samples and splenic leuko-
cyte populations prepared from uninfected or LCMV-infected mice on the 
indicated days after infection. STAT2-defi  cient, STAT1-defi  cient, or WT 
mice were used. (A) Serum IFN-      levels were measured by ELISA. Each 
circle indicates the value of an individual mouse. White circles are sam-
ples from WT mice, black circles are samples from STAT2-defi  cient mice, 
and gray circles are samples from STAT1-defi  cient mice. Black bars repre-
sent averages in each group. Sample values indicated with   §   were below 
the lower limit of detection. Data were accumulated over seven indepen-
dent experiments. (B) Contour graphs are logarithmic scale representa-
tions of the proportions of NK cells as evaluated by surface expressing 
CD49b (log y-axes), but not CD3 (log x-axes). The numbers in the graphs 
represent the percentage of NK cell means       the SEM from three mice 
in each group. (C) Histograms show the IFN-      expression in the gated 
CD49b CD3      populations. Numbers in histograms represent averages      
the SEM of percentages of positive cells, compared with the isotype con-
trols, from three mice in each group. Data are representative of more than 
three independent experiments.     2388 STATS AND TYPE 1 IFN EFFECTS ON NK CELLS | Miyagi et al.
having low STAT1 were the populations expressing pSTAT4. 
Thus, NK cells can be induced to express high STAT1 and 
IFN-      and/or pSTAT4 in vivo, but those having the highest 
levels of STAT1 do not express IFN-      or pSTAT4; this is 
particularly clear during infections of STAT2-defi  cient mice 
with delayed STAT1 induction. 
  To directly evaluate the type 1 IFN responsiveness of the 
cells having diff  erent levels of STAT1 conditioned during 
infection, splenic populations were isolated from uninfected 
or D2.5 LCMV-infected WT, STAT2-defi  cient, or STAT1-
defi  cient mice. The cells were incubated in culture for 4 h 
without stimulation, and then control treated or treated with 
IFN-      for 90 min. Flow cytometric analyses gated on the 
CD49b CD3      NK cells demonstrated that, if left with-
out cytokine stimulation, all of the NK cells had intracellular 
pSTAT4 levels returned to baseline values (  Fig. 6   compared 
with   Fig. 5 B  ), but maintained total STAT1 levels.   In vitro 
stimulation with IFN-      activated STAT4 in NK cells from all 
uninfected mice: these populations were low for STAT1 ex-
pression and dramatically responsive to IFN-      with 48  –  67% 
of the cells induced to express pSTAT4. In contrast, the NK 
cells isolated from mice on D2.5 of LCMV infection dis-
played diff  erences in pSTAT4 induction correlating with total 
STAT1 levels: 34% of the NK cells isolated from STAT1-
defi  cient mice responded to IFN-      with pSTAT4 expression, 
but those from WT and STAT2-defi  cient mice, respectively, 
were only 10 and 12% pSTAT4 positive (  Fig. 6  ). The smaller 
proportions of responders were preferentially found in cells 
At D2.5, all of the cells had shifted to express higher STAT1, 
and there was no detectable IFN-      expression. Parallel stud-
ies with STAT1 and pSTAT4 expression were performed. 
Remarkably, it was possible to spontaneously detect a 
strong pSTAT4 response within STAT2-defi  cient NK cells 
on D1.5 immediately after isolation and within STAT1-
defi  cient NK cells on D1.5 and D2.5 of infection ( Fig. 5 B ). On 
D1.5, 16  –  19% of these cells had a clear induction of pSTAT4, 
and 10% of the STAT1-defi  cient NK cells on D2.5 still 
had pSTAT4. As in the case of IFN-      expression, the cells 
  Figure 5.     Characterization of STAT1 levels in NK cells with 
in vivo  –  induced IFN-     and pSTAT4. Splenic leukocytes were prepared 
on D0, D1.5, and D2.5 of LCMV infection from WT, STAT2-defi  cient, and 
STAT1-defi  cient mice. Populations were cell surface stained for CD49b  
and CD3      to identify NK cell subsets, and intracellularly for STAT1 and 
IFN-      (A), or STAT1 and pSTAT4 (B). Dot plots represent intracellular STAT1 
(log x axes) and IFN-      (A) or pSTAT4 (B; log y axes) expression in gated 
CD49b CD3      NK cells. Three mice per group were used. Numbers within 
graphs are averages of positive cells in low or high STAT1 staining gates 
(SEMs are not      2% of results from three different mice). Data are repre-
sentative of more than three independent experiments.     
  Figure 6.     Effects of STAT2 and STAT1 defi  ciencies on conditioning 
of NK cell responsiveness for STAT4 activation. Cells were prepared 
from WT, STAT2-, and STAT1-defi  cient mice on D0 (left) and D2.5 (right) 
after LCMV infection. Responsiveness of rested cells to type 1 IFN for 
STAT4 activation was determined using splenic leukocytes incubated 
without the addition of cytokines for 4 h, and then either left unstimu-
lated or stimulated with IFN-      for 90 min. Cells were collected and 
stained to identify CD49b CD3      NK cells and detect their intracellular 
STAT1 and pSTAT4 expression using fl  ow cytometry. Dot plot graphs are 
logarithmic scale representations of the proportions of cells. Numbers 
given are means of positive cells in low or high STAT1 staining gates 
(SEMs are not      3% of results from three different mice). Data are repre-
sentative of more than three independent experiments.     JEM VOL. 204, October 1, 2007 
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reduced serum IFN-     , NK cell IFN-      expression, and NK 
cell expression of pSTAT4 in STAT2- ( Fig. 7 B ) and STAT1-
defi  cient (  Fig. 7 C  ) mice. These results demonstrate the criti-
cal in vivo contribution of type 1 IFN to IFN-      production 
by, and STAT4 activation in, NK cells stimulated under con-
ditions of reduced STAT1 protein levels. 
  Biological consequences of STAT1 and STAT2 defi  ciencies 
during LCMV infection 
  The consequences of STAT defi  ciencies for antiviral defense 
were evaluated in mice infected with LCMV for 2, 3, or 5 d. 
Spleens were harvested and viral titers were determined in 
a plaque assay. In comparison to WT mice, an increased 
susceptibility to infection was observed in both STAT1- 
and STAT2-defi  cient mice at all time points (  Fig. 8 A  ).   
In contrast, disease state as evaluated by changes in body 
weight was only apparent in STAT1-defi  cient mice (  Fig. 
8 B  ). The absence of STAT1 resulted in weight loss ranging 
having lower levels of STAT1, i.e., 7 and 9%. Therefore, type 1 
IFN induces activation of STAT4 in NK cells independently 
of STAT1 or STAT2, but once STAT1 is induced to higher 
levels, the access to STAT4 is inhibited. 
  Type 1 IFN activation of STAT4 and IFN-     in NK cell in vivo 
  To evaluate endogenous type 1 IFN exposure, the cytokines 
were measured in serum samples. Systemic levels of type I 
IFN bioactivity were observed in all three strains of mice at 
D1.5 and D2.5 of LCMV infection (  Fig. 7 A  ).    ELISA data 
indicated that both IFN-      and -      were induced (  Fig. 7 A  ). 
To defi  ne the endogenous role of type 1 IFN for NK cell 
STAT4 activation and IFN-      production in STAT1- and 
STAT2-defi  cient mice induced on D1.5 of infection, IFN-
     /      function was neutralized by administration of antibody 
blocking the receptor. In comparison to samples from con-
trol antibody  –  treated mice, blocking endogenous type 1 IFN 
function with anti-IFNAR antibody treatments dramatically 
  Figure 7.     In vivo role of type 1 IFN in NK cell STAT4 activation and IFN-      production. (A) IFN-    /     levels or IFN-      and  IFN-     levels were quanti-
fi  ed by bioassay or ELISA in serum samples taken from uninfected mice or infected mice on the indicated days after LCMV infection. Values from indi-
vidual mice are represented by white circles for WT, black circles for STAT2-defi  cient, and gray circles for STAT1-defi  cient mice. Black bars represent the 
averages in each group. The data were collected from more than six independent experiments. Dashed line represents the lower limit of detection (LD). 
(B) Responses were evaluated in STAT2-defi  cient mice on D1.5 of infection. (C) Responses were evaluated in STAT1-defi  cient mice on D1.5 of infection. 
For B and C, serum and splenic leukocytes were obtained from control antibody  –  treated or anti  –  IFNAR antibody  –  treated mice. IFN-      levels in serum were 
measured (left). Data shown are means      the SEM from three mice in each group. Cells were stained as described in the Materials and methods to analyze 
intracellular IFN-      or pSTAT4 expression within gated CD49b CD3 NK cells by fl  ow cytometry (right). The numbers in the histograms represent means      
the SEM from three mice in each group of percentages of IFN-       –  positive cells or pSTAT4-positive cells, compared with isotype controls.     2390 STATS AND TYPE 1 IFN EFFECTS ON NK CELLS | Miyagi et al.
from 10 to 15% by D3 of infection. During the same time 
period, the WT and STAT2-defi  cient mice were gaining 
weight. Thus, although both STAT1 and STAT2 are re-
quired to promote optimal defense against LCMV, STAT1, 
but not STAT2, is required for sustaining weight as a mea-
surement of health. 
  Because weight loss is an indicator of cytokine-mediated 
disease (  21  ), the involvement of IFN-      was investigated in 
the infected, STAT1-defi  cient mice. Mice were treated with 
antibody neutralizing IFN-     . In comparison to control treat-
ments, inhibition of IFN-      provided signifi  cant protection 
from virus-induced wasting at the critical D3 (  Fig. 8 C  ). Be-
cause NK cells were major producers of the IFN-      response, 
their contribution to disease was evaluated by treating mice 
with antibodies deleting the cells. NK cell depletion also pro-
vided protection from maximal virus-induced wasting (  Fig. 
8 D  ). Collectively, these data demonstrate that the absence of 
either STAT1 or STAT2 results in increased sensitivity to 
viral infection and increased IFN-      at the earliest time points, 
but that sustained IFN-      production and an NK-cell  –   and 
IFN-       –  dependent disease are only induced in the absence of 
STAT1. Thus, STAT1, in the presence or absence of STAT2, 
promotes the regulation of NK cell responses and protects 
against cytokine disease. 
  STAT associations with the type 1 IFN receptor 
  The aforementioned studies demonstrate that type 1 IFNs 
can activate STAT4 in NK cells with their high basal levels of 
this signaling molecule, but not in populations with low 
STAT4 expression. Moreover, they show that even in the 
presence of high STAT4, this pathway of activation is lost 
during viral infection at times correlating with elevated 
STAT1 expression. STAT1 is associated with the IFNAR 
before cytokine exposure in cultured fi  broblasts (  32  ), but lit-
tle is known about its association in freshly isolated leuko-
cytes from uninfected and infected mice, and the association 
of STAT4 with the receptor has not been tested under these 
conditions. To defi  ne the physical interactions between 
IFNAR and the STATs and advance the mechanism under-
standing of the loss in STAT4 access, experiments evaluating 
coprecipitation with the receptor were performed. The anti-
body used has been shown to immunoprecipitate IFNAR 
(  33  ). Total, NK (enriched by CD49b-positive selection), and 
non-NK (CD49b-negative selection) populations isolated 
from uninfected WT were evaluated. Immunoprecipitations 
were performed with cell lysates. Total input proteins, as well as 
precipitated proteins, were characterized by Western blot anal-
ysis. Controls were total lysates from IFNAR-, STAT1-, and 
  Figure 8.     Role of STAT1 or STAT2 in antiviral defense and disease 
progression. (A) Spleens, isolated from uninfected or infected WT, STAT1-
defi  cient, or STAT2-defi  cient mice on the indicated days after LCMV infec-
tion, were processed to quantify the viral titers in a plaque assay. Each 
circle indicates the value of an individual mouse. Black bars represent 
averages in each group. Data are the accumulated results from more than 
six independent experiments. Dashed line represents the lower limit of 
detection (LD). Sample values, which are indicated with   §  , were below the 
lower limit of detection. For A and B, white circles are results from WT 
mice, black circles indicate results from STAT2-defi  cient mice, and gray 
circles are results from STAT1-defi  cient mice. (B) Disease was evaluated by 
changes in body weights. Uninfected or infected mice were monitored for 
their body weight once a day from D0 to D5. Percentage of body weight 
changes compared with D0 value is shown. Data represent the mean       
the SEM from 10 mice in each group. (C) The role for IFN-      in disease was 
tested.  Anti – IFN-     antibody – treated  or  control  Ig-treated  STAT1-defi  cient 
mice were monitored for their body weight changes on D3 after LCMV 
infection. The percentage of body weight losses is shown. Gray circles 
represent the values of individual control Ig-treated and gray squares 
represent  anti – IFN-     antibody  –  treated mice. Black bars represent aver-
ages. Data are from six mice in each group. Differences between control 
Ig – treated  STAT1-defi  cient mice and anti  –  IFN-      antibody – treated  STAT1-
defi  cient mice are signifi  cant at P       0.003. (D) The role for NK cells in 
disease was tested by depleting the cells with anti-AGM1 treatments. 
Anti – AGM1  antibody – treated  or  control  Ig – treated  STAT1-defi  cient mice 
were monitored for their body weight changes on D3 after LCMV infec-
tion. The percentages of body weight loss are shown. Gray circles repre-
sent individual control Ig  –  treated and gray triangles represent anti  –  AGM1 
antibody  –  treated mice. Black bars represent averages. Data are from fi  ve 
mice in each group. Differences between control Ig-treated STAT1-defi  cient 
mice  and  anti – AGM1  antibody – treated  STAT1-defi  cient mice are signifi  cant 
at P       0.05.   JEM VOL. 204, October 1, 2007 
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    DISCUSSION   
  These studies demonstrate that high basal STAT4 predisposes 
NK cell type 1 IFN responses to include STAT4 activation 
and IFN-      production, but that the pathway is tightly regu-
lated by type 1 IFN and IFN-      induction of STAT1. In-
creased activation of STAT1 and a switch in a STAT4 to a 
STAT1 association with the type 1 IFN receptor accompany 
the change in access to STAT4. The results signifi  cantly ad-
vance the understanding of mechanisms regulating fl  exibility 
in the signaling pathways shaping type 1 IFN eff  ects by add-
ing the importance of the role for high basal STAT4 levels 
and type 1 IFN receptor interactions in promoting particular 
responses, and for STAT1 induction in interfering with these. 
In addition, they defi  ne the biological relevance of individual 
branches in the context of in vivo viral infection by showing 
that both STAT1 and STAT2 are required for optimal viral 
control, but that the presence of STAT1 has a unique and impor-
tant function, independent of STAT2, for protecting against 
IFN-       –  enhanced disease. Collectively, the observations prove 
that individual STAT levels are used as mechanisms for both 
shaping fundamental characteristics of cell subsets and condi-
tioning cellular responses during infection. 
  The high basal levels of STAT4 in   Fig. 1   and the STAT4 
association with the type 1 IFN receptor on (  Fig. 9  ) NK cells 
discovered in this study are novel and surprising fi  ndings. 
Although a few examples of matured or activated monocyte/
dendritic cells with high STAT4 have been reported (  35, 36  ), 
the regulation of STAT4 expression has not been defi  ned, 
and levels have not been studied in freshly isolated cells from 
control conditions. Likewise, low basal association of STAT1 
with the type 1 IFN receptor has been seen in culture stud-
ies (  32  ), but the consequences of high STAT4 on IFNAR 
associations have not been previously examined. The results 
challenge the model of ligand-driven stimulation for STAT 
binding to cytokine receptors, which is based largely on the 
characterization of molecular events within a limited range 
of cell types in culture. The basal IFNAR association with 
STAT4 in NK cells was not predicted by existing information, 
and raises exciting possibilities about how levels of diff  erent 
STATs might act to provide particular cell lineages fl  exibility 
in accessing subset type 1 IFN eff  ects with low levels of the 
cytokines (  Fig. 10  ).   
  The increased STAT1 association with IFNAR in all pop-
ulations after STAT1 induction is consistent with exist-
ing models, but adds information concerning their sustained 
interactions. Type 1 IFN activation of STAT4 and IFN-      ex-
pression suggests that NK cells may be an early source of this 
cytokine, at times preceding STAT1 induction, but that the 
induction of elevated STAT1 levels, through either the type 1 
IFN or IFN-      receptors, regulates type 1 IFN enhancement 
of IFN-      production. Thus, the type 1 IFN pathway to pro-
moting IFN-      production is inhibited when NK cells sense 
the product in the environment, and would be under any 
conditions of IFN-      exposure. In this way, induction of 
STAT1 by IFN-      can be seen as part of a feedback inhibi-
tion system. Conversely, however, STAT1 is important in the 
STAT4-defi  cient mice, and control immunoglobulin pre-
cipitation (  Fig. 9  ).   There was a signifi  cant preassociation of 
STAT4 with IFNAR in NK cells, but not in non-NK or total 
cells, prepared from uninfected mice (  Fig. 9 A  , lanes 1  –  3). 
To eliminate the possibility of secondary eff  ects induced dur-
ing positive selection, the experiments were repeated with 
populations enriching NK cells by negative selection. The 
STAT4 preassociation with IFNAR was also observed with 
these NK cells (  Fig. 9 B  ). Only low levels of STAT1 were 
coprecipitated with the receptor in any of the populations 
from uninfected mice. 
  The type 1 IFN response to LCMV can be detected for 
up to 4 d after infection (  26, 29  ). Because the binding of 
the IFNAR antibody is inhibited in the presence of the re-
ceptor ligand (  33  ), and because the total STAT1 levels are 
increased for up to 5 d after infection (  10, 34  ) (unpublished 
data), the experiments to evaluate the consequences of in-
creased STAT1 on STAT4 binding were performed with 
cells prepared on D5. At this time, STAT4 binding to 
IFNAR was signifi  cantly decreased in NK cells, despite sus-
tained STAT4 levels (  Fig. 9 A  , lane 5). However, all three 
populations, including NK cells, had markedly increased as-
sociations with the elevated STAT1 (  Fig. 9 A  , lanes 4  –  6). 
Thus, STAT interactions with the type 1 IFN receptor are 
dramatically regulated in the context of viral infection, and 
the type 1 IFN receptor on NK cells changes from having a 
STAT4 to a STAT1 association. 
  Figure 9.     STAT associations with the type 1 IFN receptor. Total 
splenic leukocytes, NK, and non-NK cells were prepared from uninfected 
(D0) or LCMV-infected WT mice on D5, as described in the Materials and 
methods. (A) NK cell purifi  cations were based on positive cell enrichments. 
(B) NK cells were enriched by negative selection. The association of STAT1 
or STAT4 was determined by the coimmunoprecipitation of STAT1 and 
STAT4 with IFNAR (A, lanes 1  –  6; B, lanes 1  –  3). Input sample was also ex-
amined (A, lanes 8  –  13; B, lanes 5  –  7). The specifi  city of the association was 
confi  rmed by the detection of the immunoreactive bands in cell lysates 
from WT, but not those from IFNAR-, STAT1-, or STAT4-defi  cient cells. The 
results showing STAT4 association with IFNAR on NK cells were obtained 
in three independent experiments, and the STAT1 associations with 
IFNARs after infection were repeated in two independent experiments.     2392 STATS AND TYPE 1 IFN EFFECTS ON NK CELLS | Miyagi et al.
in STAT2-defi  cient mice once STAT1 levels are induced 
by IFN-      (  Figs. 5 and 6  ). It is interesting to note that the 
basal levels of STAT1 in NK cells are lower than those in 
other populations (  Figs. 1 and 2  ). As STAT1 is induced by 
type 1 IFN, the presence of high STAT4 in NK cells might 
dampen endogenous low-level signaling through STAT1  –
  STAT2 to result in lower STAT1 levels. This would provide 
the cells with another mechanism for promoting basal type 1 
IFN activation of STAT4, e.g., less competition by STAT1. 
The fi  ne details of molecular interactions between STAT2, 
STAT1, and STAT4 under basal and infection conditions are 
currently being defi  ned. 
  Use of the STAT2-defi  cient mice and fl  ow cytometry 
to evaluate responses within individual cells greatly facilitated 
these studies. The delayed STAT1 induction in the STAT2-
defi  cient mice made it possible to capture NK cell IFN-      
expression in vivo, and to watch it disappear as the STAT1 
levels increase. The NK cell responses in STAT2-defi  cient 
mice parallel those in STAT1-defi  cient mice on D1.5, but 
those in WT mice once their STAT1 levels are increased on 
D2.5 of infection (  Figs. 3  –  5  ). This is true, even though both 
STAT1- and STAT2-defi  cient mice have increased viral bur-
dens (  Fig. 8  ). The intracellular analysis of STAT1, along with 
pSTAT4, allows a precise approach for capturing the type 1 
IFN signal proximal to the receptor and evaluating the levels 
of both within a single cell (  Fig. 5  ). The experiments block-
ing type 1 IFN receptor function in vivo clearly demonstrate 
that the STAT4 activation is dependent on this receptor 
and its cytokines (  Fig. 7  ). To our knowledge, this is the fi  rst 
defi  nition of the activation of a particular signaling pathway 
within individual cells during an in vivo infection. The stim-
ulation of pSTAT1 with short-term IFN-      exposure, using 
cells isolated from uninfected or infected mice, demonstrates 
that when STAT1 levels are high the block is in access to 
STAT4, but not STAT1 (  Fig. 2  ). These results help exclude 
a role for the suppressor of cytokine signaling 1 (SOCS1) in 
regulating access to STAT4 because this mediator would also 
be expected to block STAT1 activation (  40  ). There is, how-
ever, a possibility that SOCS1 may help favor the STAT4 
pathway by blocking access to low levels of STAT1 (  41, 42  ), 
and that during infection, increasing STAT1 concentrations 
act to overcome this suppression and help change STAT pref-
erences. Characterization of the contributions made by the 
various SOCS to the balance between STAT4 and STAT1 
activation is beyond the scope of this study, but these mol-
ecules have the potential to help in the selection of type 1 
IFN activation pathways. 
  In agreement with the previously reported sensitivity to 
vesicular stomatitis virus replication (  43  ), but in contrast to 
the appearance of the LCMV-induced wasting disease in only 
the STAT1-defi  cient conditions reported in this study, the 
induction of an optimal antiviral state during LCMV infection 
depends on the presence of both STAT1 and STAT2. Because 
WT mice have elevated STAT1 and are protected from 
the virus during infection, access of type 1 IFN to STAT2-
dependent antiviral eff  ects must remain intact, even when 
stimulation of direct antiviral mechanisms, as well as increased 
NK cell cytotoxicity (  15, 37  ) and interleukin-15 production 
by other cell types (  15, 38  ). The substitution of STAT1 for 
STAT4 in NK cells and the elevated STAT1 association with 
IFNAR in all tested cells after infection suggests that increas-
ing STAT1 may provide a common mechanism for cells to 
switch to stimulating gene targets activated through STAT2  –
  STAT1 or STAT1  –  STAT1 complexes (  5, 6  ). 
  Although the activation of STAT4 is clearly decreased 
and a STAT4 association with IFNAR is replaced by STAT1 
when STAT1 is induced, the precise molecular changes re-
sponsible for this remain to be elucidated. There is a possi-
bility that phosphorylation of the receptor  ’  s cytoplasmic tail 
driven by cytokine binding results in conditions less favorable 
for STAT4 binding, but more favorable for STAT1 binding. 
However, the levels of STAT1 appear to be a critical ingre-
dient because, in addition to being preferentially activated in 
NK cells from all tested uninfected mice (  Figs. 2 and 6  ) even 
though STAT1 is present, STAT4 is activated in a type 1 IFN-
dependent manner in NK cells from the STAT2  −  mice ex-
posed to type 1 IFN at D1.5 of infection (  Figs. 5 and 7  ). 
Direct competition between STAT1 and STAT3 for binding 
to the IFN-      receptor has been reported (  39  ), but STAT2 
is important for type 1 IFN receptor access to STAT1 (  5, 6  ). 
Even if STAT2 facilitates type 1 IFN receptor access to 
STAT1 (  5, 6  ), however, it does not appear to be necessary 
for blocking type 1 IFN access to STAT4 because it occurs 
  Figure 10.     Model. A model for the events characterized in this study is 
presented. NK cells are predisposed to respond to type 1 IFN activation of 
STAT4 because they have higher basal levels of this molecule than other 
cell types and it is associated with the receptor. Stimulation can result in 
IFN-      production. However, both type 1 IFN, through STAT2-dependent 
pathways, and IFN-     , through STAT2-independent pathways, can help 
promote increased expression of STAT1, and this response helps regulate 
type 1 IFN access to STAT4 and IFN-     . Cell types that do not have high 
basal STAT4 respond to type 1 IFN with STAT1 activation and induction 
of the signaling molecule.     JEM VOL. 204, October 1, 2007 
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M. Kaplan (Indiana University School of Medicine, Indianapolis, IN), and of 
STAT1-defi  cient (  51  ) mice were obtained from J. Durbin. Mice were bred 
and maintained in isolation facilities at Brown University through brother  –
  sister mating. All mice used in experiments were 5  –  12 wk old. Animals ob-
tained from sources outside of Brown University were housed in the animal 
care facility for at least 1 wk before use. Handling of mice and experimental 
procedures were conducted in accordance with institutional guidelines for 
animal care and use. 
  Virus, infections, and in vivo treatment protocols.     All experiments 
were initiated on D0. Mice were either not infected or i.p. infected with 
2   ×   10  4   PFUs of LCMV Armstrong strain clone E350 (  13, 26  ). For in vivo 
neutralization of IFN-     , 1 mg of anti  –  IFN-      antibody (XMG1.2; prepared 
by and purchased from BioExpress) or the same amount of Rat IgG control 
antibody (Sigma-Aldrich) was injected i.p. 4 h before infection. For ex-
periments on in vivo blocking of IFNAR function, 2.5 mg of monoclonal 
anti  –  mouse IFNAR antibody, or the same amount of isotype control anti-
body, was injected i.p. 4 h before infection. The anti-IFNAR antibody and the 
control antibody were gifts from R.D. Schreiber (Washington University School 
of Medicine, Saint Louis, MO) (  52  ). In vivo NK cell depletion was performed 
with antibody against asialo-ganglio   N  -tetraoglyceramide (AGM1) as previously 
described (  13, 53, 54  ). Responses were compared with animals receiving normal 
rabbit immunoglobulin. 
  Sample preparations.     On the indicated days after the initiation of exper-
iments, serum samples, spleen tissue homogenates, and splenic leukocytes 
were prepared as previously described (  10, 13, 15, 31, 55  ). 
  Flow cytometric analyses.     To detect intracellular IFN-     , STAT1, 
STAT4, pSTAT1, and pSTAT4, approaches were developed as modifi  ca-
tions of published studies (  13, 15, 26, 34, 56, 57  ). In brief, in the STAT1, 
pSTAT1, and pSTAT4 studies, cells were fi  rst labeled for surface staining 
with FITC-conjugated anti-CD49b antibody (DX5). A PE-conjugated anti-
STAT1 (clone #42) (  34  ), Alexa Fluor 647  –  conjugated anti-STAT4 pY693 
(38/p-Stat4), and PE-conjugated anti-STAT1 pY701 antibody (4a) were 
used. For the STAT4 studies, biotin-conjugated anti-CD49b antibody (DX5) 
was used with streptavidin-APC, and the anti-STAT4 antibody (clone #8) 
was used with FITC-conjugated anti  –  mouse IgG1 antibody (A85-1). Anti-
bodies were purchased from BD Biosciences. The PE-conjugated STAT1 
was a customized preparation. Cold pure methanol incubation was used for 
permeabilization. A PerCP-conjugated anti-CD3      antibody (145-2C11) was 
used after intracellular staining because methanol treatment diminished the 
intensity of this stain. Corresponding isotypes were used as controls. For the 
test of colocalization of STAT1 with IFN-     , cells were stained with FITC-
conjugated anti-CD49b antibody (DX5) and PerCP-conjugated anti-CD3      
antibody (145-2C11), fi  xed, and permeabilized with Cytofi  x/Cytoperm 
(BD Biosciences,), incubated with DNase (Sigma-Aldrich) at 37  °  C for 1 h, 
and stained with PE-conjugated anti-STAT1 antibody and APC-conjugated 
anti  –  IFN-      antibody (XMG1.2) or corresponding isotype controls. Samples 
were acquired using a FACSCalibur (BD Biosciences), with the CellQuest 
Pro software. Laser outputs were 15 mW at 488- and 635-nm wavelengths. 
At least 100,000 events were collected within the leukocyte gate for analysis. 
Specifi  city of staining for STAT1 and pSTAT1 was demonstrated using cells 
isolated from STAT1-defi  cient mice (  50, 51  ), and for STAT4 and pSTAT4 
using cells isolated from STAT4-defi  cient (  47  ) mice. Isotype control anti-
bodies included mouse IgG2a, mouse IgG2b, and mouse IgG1, all of which 
were obtained from BD Biosciences. 
  NK cell enrichment.     Populations were processed to isolate NK cells by 
positive selection of CD49b-positive cells or by depletion of non-NK cells, 
respectively using anti-CD49b magnetic beads or the NK Cell Isolation kit 
(Miltenyi Biotec) according to the manufacturer  ’  s instructions. The splenic 
leukocytes were incubated on polystyrene plates for 90 min at 37  °  C before 
being used to exclude macrophages and increase the purity of selected cells. 
The separated populations were analyzed by fl  ow cytometry immediately after 
STAT1 levels are increased. A remarkable observation re-
ported in this study, however, is that the IFN-       –  dependent 
disease resulting from STAT1 defi  ciency during LCMV infec-
tion must be activated through STAT1-independent path-
ways. There are indications that the STAT1 regulation of 
type 1 IFN access to STAT4 might have a parallel in STAT1 
regulation of IFN-      access to STAT3 (  39  ). IFN-      can activate 
either STAT1 or STAT3, and there are examples of gene 
targets for this cytokine that are STAT1-dependent, STAT1-
independent, and/or revealed in the absence of STAT1 
(  44, 45  ). Thus, changing access to diff  erent STAT signaling 
pathways may also regulate the range of IFN-       –  mediated 
biological eff  ects. 
  In contrast to the well-characterized downstream targets 
of STAT1  –  STAT2 and/or STAT1  –  STAT1 signaling for gene 
expression (  5  ), the understanding of the contributions made 
by STAT4 signaling is still limited (  46  ). This signaling mole-
cule is clearly important in the activation of IFN-     , and has 
been best studied for its role in response to interleukin-12 
(  14, 15, 47  ). In both the human and mouse systems, however, 
type 1 IFN can also activate STAT4 (  3, 9, 16, 17, 19, 20  ), and 
the signaling molecule contributes to type 1 IFN-mediated 
enhancement of an endogenous T cell IFN-      response during 
LCMV infection (  10, 26  ). Thus, there are likely to be mech-
anisms in place to promote type 1 IFN access to STAT4, in 
addition to higher basal STAT4 levels. Ongoing studies in 
the laboratory are evaluating T cell responses to type 1 IFN 
and the regulation of a STAT4 contribution to these during 
viral infections. 
  In summary, this careful examination of signaling in the 
context of intact biological responses has resulted in several 
surprises concerning the regulation of cytokine eff  ects. The 
data reported demonstrate that regulation of basal levels of 
particular STATs and their receptor association fundamen-
tally contributes to an important and characteristic function 
of NK cells: innate IFN-      production. They also help ex-
plain why it is necessary to regulate STAT levels and how 
this is done in the context of an in vivo viral infection. The 
picture emerging is one whereby fl  exible use of cytokines, 
receptors, and signaling molecules has evolved to orches-
trate complex biological responses. As defi  ned by this work, 
the sorting of signaling molecules and their concentrations 
to shape the consequences of exposure to the same cytokines 
provide mechanisms for extending the value of a limited set 
of genes. 
    MATERIALS AND METHODS   
  Mice.     Specifi   c pathogen-free WT 129SvEv mice were purchased from 
Taconic. Breeding pairs of mice mutated in the IFNAR-, IFN-     R-, or 
IFN-     /     /     R-gene (  48, 49  ) on the 129 background were either originally 
purchased from B  &  K Universal Limited or were provided by J. Durbin 
(Children  ’  s Hospital and Research Institute, Columbus, OH). Breeding pairs 
of the STAT2-defi  cient 129 mice were a gift from C. Schindler (Columbia 
University, New York, NY) (  43  ); breeding pairs of the STAT1-defi  cient 
129 mice (  50  ) were purchased from Taconic. For additional experiments 
evaluating specifi  city of staining and Western blots, breeding pairs on the 
C57BL/6 background of STAT4-defi  cient mice (  47  ) were obtained from 2394 STATS AND TYPE 1 IFN EFFECTS ON NK CELLS | Miyagi et al.
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